Platelet aggregation and activation in thalassemia major patients in Indonesia

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 3, 2008, Pages 346-351

  Setiabudy, Rahajuningsih ^a,b   Wahidiyat, Pustika Amalia ^a   Setiawan, Lyana ^a  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b NONE   (Indonesia)

Author keywords

thalassemia HbE; thromboglobulin; Platelet activation; Platelet aggregation; Thalassemia major

Indexed keywords

BETA THROMBOGLOBULIN; D DIMER; HEMOGLOBIN E;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; SPLENECTOMY; THALASSEMIA MAJOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; THROMBOSIS;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BETA-THROMBOGLOBULIN; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INDONESIA; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; RISK FACTORS; SPLENECTOMY; THROMBOEMBOLISM;

EID: 45749091373     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607306397     Document Type: Article

References (27)

1. Weatherall DJ Genetic disorders of haemoglobin. In: Hoffbrand AV, Lewis SM, Tuddenham EGD, eds. Postgraduate Haematology. 4 th ed. Oxford, UK: Butterworth Heinemann ; 1999: 91-119.
2. McKenzie SB Anemias caused by abnormalities in globin biosynthesis. In: Donna B, Vicki V, eds. Textbook of Hematology. 2nded. Baltimore, MD: Williams & Wilkins; 1996: 147-178.
3. Setianingsih I. β-Thalassemia in Indonesia: Molecular Basis and Phenotype-Genotype Correlation [thesis]. Melbourne, Australia: The University of Melbourne ; 2000.
4. Flint J., Harding RM, Boyce AJ, Clegg JB The population genetics of the haemoglobinopathies. In: Higgs DR, Weatherall DJ, eds. Baillière's Clinical Haematology. London, England: Bailliere-Tindal l; 1993: 215-262.
5. Atmakusuma TD Anti-Phospholipid Antibody in Adult Beta-Thalassemia Patients: Analysis of Potential Factors That Cause Its Increase and Its Association With Haemostatic Disorders [doctoral dissertation]. Jakarta: University of Indonesia ; 2005.
6. Sonakul D., Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992 ; 23: 25-31.
7. Canatan D., Zorlu M., Bayor N., et al. Thrombosis after splenectomy in patients with thalassemia. Turk J Haematol. 2001 ; 18: 259-263.
8. Borgna-Pignatti C., Carnelli V., Caruso V., et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998 ; 99: 76-79.
9. Eldor A., Rachmilewitz EA The hypercoagulable state in thalassemia. Blood. 2002 ; 99: 36-43.
10. Gurney D., Lip GYH, Blann AD A reliable plasma marker of platelet activation: does it exist ? Am J Haematol. 2002 ; 70: 139-144.
11. Fareed J., Bick RL, Hoppensteadt DA, Bermes EW Molecular markers of hemostatic activation: applications in the diagnosis of thrombosis and vascular and thrombotic disorders. Clin Appl Thromb Hemost. 1995 ; 1: 87-102.
12. Helena platelet aggregation reagents [package insert]. Beaumont, TX: Helena Laboratories ; 1996.
13. Asserachrom ® β-TG [package insert]. Asnieres-Sur-Seine, France: Diagnostica Stago ; 1998.
14. Logothetis J., Constantoulakis M., Economidou J., et al. Thalassemia major (homozygous β-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology. 1972 ; 22: 294-304.
15. Hirsh J., Colman RW, Marder VJ, George JN, Clowes AW Overview of thrombosis and its treatment. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 1071-1084.
16. Winichagoon P., Fucharoen S., Wasi P. Increased circulating platelet aggregates in thalassemia. Southeast Asian J Trop Med Public Health 1981 ; 12: 556-560.
17. Eldor A., Lellouche F., Goldfarb A., Rachmilewitz EA, Maclouf J. In vivo platelet activation in β thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood. 1991 ; 77: 1749-1753.
18. Atichartakarn V., Angchaisuksiri P., Aryurachai K., Chuncharunee S., Thakkinstian A. In vivo platelet activation and hyperaggregation in hemoglobin E/β-thalassemia: a consequence of splenectomy. Int J Hematol. 2003 ; 77: 299-303.
19. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981 ; 57: 199-202.
20. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR Complications of β-thalassemia major in North America. Blood. 2004 ; 104: 34-39.
21. Lewis SM The spleen. In: Hoffbrand AV, Lewis SM, Tuddenham EGD, eds. Postgraduate Haematology. 4 th ed. Oxford, UK: Butterworth Heinemann ; 1999: 323-335.
22. Ruf A., Pick M., Deutsch V., Patscheke H., et al. In vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997 ; 98: 51-56.
23. Keaney JF, Simon DI, Freedman JE Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 1999 ; 13: 965-976.
24. Unchern S., Laoharuangpanya N., Phumala N., et al. The effects of vitamin E on platelet activity in β-thalassaemia patients. Br J Haematol. 2003 ; 123: 738-744.
25. Hussain MAM, Hutton RA, Pavlidou O., Hoffbrand AV Platelet function in beta thalassemia major. J Clin Pathol. 1979 ; 32: 429-433.
26. Setiabudy-Dharma R., Funahara Y. Enhancement of collagen-induced aggregation of platelets in whole blood. Thromb Res. 1986 ; 42: 621-634.
27. Capellini MD, Robbiolo L., Bottasso BM, Coppola R., Fiorelli G., Manucci PM Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br J Haematol. 2000 ; 111: 467-473.